Fluorescein versus Indocyanine Green Angiography Guided Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

被引:1
|
作者
Moodi, Farzan [1 ,2 ]
Naseripour, Masood [1 ,2 ,3 ]
Zand, Amin [1 ,2 ]
Mirshahi, Reza [1 ,2 ]
Moodi, Vihan [4 ]
Alemzadeh, Sayyed Amirpooya [1 ,2 ]
Falavarjani, Khalil Ghasemi [1 ,2 ,3 ,5 ]
机构
[1] Iran Univ Med Sci, Senses Hlth Inst 5, Eye Res Ctr, Rassoul Akram Hosp,Sch Med, Tehran, Iran
[2] Iran Univ Med Sci, Senses Hlth Inst 5, Dept Ophthalmol, Rassoul Akram Hosp,Sch Med, Tehran, Iran
[3] Iran Univ Med Sci, Stem Cell & Regenerat Med Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[5] Rassoul Akram Hosp, Eye Res Ctr, Sattarkhan Niaiesh St, Tehran 14456, Iran
关键词
Central Serous Chorioretinopathy; Fluorescein Angiography; Indocyanine Green Angiography; Photodynamic Therapy; VERTEPORFIN;
D O I
10.18502/jovr.v19i1.15420
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare the outcomes of fluorescein angiography (FA)-guided and indocyanine green angiography (ICGA)-guided half-dose photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (CSC). Methods: In this retrospective comparative study, medical records of eyes with chronic CSC who underwent half-dose PDT were reviewed. A retina specialist performed FA-guided half-dose PDT, and the other performed ICGA-guided treatment. The success of applying PDT in the resolution of subretinal fluid was compared between the FA- and ICGA-guided methods. Results: Eighty-two eyes of 73 patients (41 eyes in each group) received half-dose PDT. After halfdose PDT, a significant improvement in the best-corrected visual acuity (BCVA) was found at the time of the last follow-up in both groups (both P < 0.001), with no significant intergroup difference. Central subfield and subfoveal choroidal thicknesses decreased significantly in both groups at the last follow-up (all P < 0.05), with no significant differences between the groups. Subretinal fluid (SRF) resolved in all eyes, and no persistent SRF was detected during the follow-up period. Conclusion: FA-guided and ICG-guided half-dose PDT may have similar efficacy for the treatment of chronic CSC.
引用
收藏
页码:12 / 17
页数:6
相关论文
共 50 条
  • [41] Angiographic and Tomographic Prognostic Factors of Chronic Central Serous Chorioretinopathy Treated with Half-Dose Photodynamic Therapy
    Chung, Chung Yee
    Chan, Yee Yan
    Li, Kenneth K. W.
    OPHTHALMOLOGICA, 2018, 240 (01) : 37 - 44
  • [42] Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy
    Tseng, Chien-Chi
    Chen, San-Ni
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (08) : 1070 - 1077
  • [43] Findings of OCT-angiography compared to fluorescein and indocyanine green angiography in central serous chorioretinopathy
    Min, Jing-Yu
    Lv, Yanan
    Yu, Suqin
    Gong, Yuan-Yuan
    LASERS IN SURGERY AND MEDICINE, 2018, 50 (10) : 987 - 993
  • [44] Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Atik, Alp
    Hu, Yijun
    Yu, Honghua
    Yang, Chun
    Cai, Bin
    Tao, Yijing
    Li, Dongli
    Chen, Yan
    Lu, Li
    Li, Guodong
    Yuan, Ling
    BMC OPHTHALMOLOGY, 2017, 17
  • [45] Short-Term Choriocapillaris Changes in Patients with Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy
    Nassisi, Marco
    Lavia, Carlo
    Alovisi, Camilla
    Musso, Luca
    Eandi, Chiara M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (11):
  • [46] Half-dose photodynamic therapy for chronic central serous chorioretinopathy evaluated by focal macular electroretinograms
    Oiwa, Kazuhiro
    Kataoka, Keiko
    Maruko, Ruka
    Ueno, Shinji
    Ito, Yasuki
    Terasaki, Hiroko
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2017, 61 (03) : 260 - 266
  • [47] QUANTIFICATION OF METAMORPHOPSIA IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY AFTER HALF-DOSE VERTEPORFIN PHOTODYNAMIC THERAPY
    Fujita, Kyoko
    Imamura, Yutaka
    Shinoda, Kei
    Matsumoto, Celso Soiti
    Mizutani, Yoshihiro
    Mizota, Atsushi
    Yuzawa, Mitsuko
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (05): : 964 - 970
  • [48] Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes
    S H Karakus
    B Basarir
    E Y Pinarci
    E U Kirandi
    A Demirok
    Eye, 2013, 27 : 612 - 620
  • [49] Optical coherence tomography angiography-guided vs indocyanine green angiography-guided half-dose photodynamic therapy for acute central serous chorioretinopathy: 6-month randomized trial results
    Li, Siying
    Zhang, Linqi
    Tang, Jiyang
    Wang, Zongyi
    Qu, Jinfeng
    Zhao, Mingwei
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 261 (11) : 3149 - 3158
  • [50] Microperimetric changes and fixation stability status after half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Gulkas, Samet
    Sahin, Ozlem
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (05) : 1053 - 1060